| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |